A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer's disease-Reference-Cited by-同舟云学术

A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer's disease

Published:2024-09-03 Issue:1 Volume:13 Page:
ISSN:2047-9158
Container-title:Translational Neurodegeneration
language:en
Short-container-title:Transl Neurodegener

Author:

Tagai Kenji,Tatebe Harutsugu,Matsuura Sayo,Hong Zhang,Kokubo Naomi,Matsuoka Kiwamu,Endo Hironobu,Oyama Asaka,Hirata Kosei,Shinotoh Hitoshi,Kataoka Yuko,Matsumoto Hideki,Oya Masaki,Kurose Shin,Takahata Keisuke,Ichihashi Masanori,Kubota Manabu,Seki Chie,Shimada Hitoshi,Takado Yuhei,Kawamura Kazunori,Zhang Ming-Rong,Soeda Yoshiyuki,Takashima Akihiko,Higuchi Makoto,Tokuda Takahiko

Funder

Japan Agency for Medical Research and Development

MEXT KAKENHI

Core Research for Evolutional Science and Technology

Moonshot Research and Development Program

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s40035-024-00439-4.pdf

Reference10 articles.

1. Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324:772–81.

2. Karikari TK, Ashton NJ, Brinkmalm G, Brum WS, Benedet AL, Montoliu-Gaya L, et al. Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility. Nat Rev Neurol. 2022;18:400–18.

3. Palmqvist S, Tideman P, Cullen N, Zetterberg H, Blennow K. Alzheimer’s Disease Neuroimaging Initiative, et al. Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures. Nat Med. 2021;27:1034–42.

4. Therriault J, Vermeiren M, Servaes S, Tissot C, Ashton NJ, Benedet AL, et al. Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography. JAMA Neurol. 2023;80(2):188–99.

5. Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Schöll M, Strandberg O, et al. Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2018;320:1151–62.